Clinical Trials: Letter from the SME office of the EMA
The Small and Medium-sized Enterprises (SME) office of the European Medicines Agency (EMA) has written to stakeholders on the situation … read more »
ANSM adapts to COVID-19
The French Medicines Agency has set up new ways of working to ensure it is functioning well during the coronavirus … read more »
Reports show effects of coronavirus on the Nordic industry
Nordic Life Science is reporting the effects so far of the coronavirus pandemic on the life sciences industry in Sweden … read more »
Medicine designed by AI to progress to human trials
British company shows artificial intelligence (AI) cuts drug development time and can lead to clinical trials in as little as … read more »
NIHR open new site: Delivering complex and innovative trials
The National Institute of Health Research (NIHR) has launched a new page to describe its role in the use of … read more »
European bodies launch further push for publication of clinical trial results
The European Medicines Agency has called for improved publication rates for clinical trials, with 5,855 of a possible 18,432 as … read more »
Record year for clinical research studies
The NIHR has reported that the past 12 months has seen a record number of new clinical studies, as well … read more »
Further official guidance on Brexit disruption
The Chief Commercial Officer at the Department of Health and Social Care (DHSC), Steve Oldfield, has written to industry with … read more »
EMA Management Board March 2019 Meeting: Key Takeaways
The European Medicines Agency (EMA) Management Board has held its first meeting in its new premises in Amsterdam, and under … read more »
England’s Chief Medical Officer calls for industry to conduct trials into medicinal cannabis
England’s Chief Medical Officer, Professor Dame Sally Davies, has called on industry to play a leading role in conducting clinical … read more »
